Shree Ganesh Bio, a company in the Biotechnology industry, reported revenue of ₹0.16 crore and a net loss of ₹0.08 crore for the September 2026 quarter.
Shree Ganesh Bio (BSE: SHREEGANES) closed at ₹0.44 on 20 Nov 2026, down 34.3% over the past year. Its market capitalisation is ₹18 crore.
Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.